Pulished Date August, 2019
ID: 2268
Share on
Share on

Asia-Pacific Antacid Market Research Report – Segmented By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, And Pro-motility Agents), By Formulation Type (Tablet, Liquid And Powder), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Others) and By Country (China, India, Japan, Australia, South Korea and Rest of APAC) -Industry Analysis on Size, Share, Growth, Trends and Forecast | 2019 - 2024

Pulished: August, 2019
ID: 2268
Pages: 145

Asia-Pacific Antacid Market Size and Growth (2019-2024):

Asia-Pacific Antacid Market Size value was worth USD 2.92 billion in 2019 and estimated to be growing at a CAGR of 4.0%, to reach USD 3.55 billion by 2024. 

Asia Pacific Antacids are a group of medications that helps in neutralize the content of acid reflux in the stomach. It provides fast relief of heartburn, one of the main symptoms of gastroesophageal reflux digestion and other symptoms are nausea, bloating or belching. Antacids include magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids incorporate magnesium carbonate, aluminium hydroxide, and magnesium trisilicate. A few people have announced unfavourably susceptible responses to antacids.

The growing trend toward self-medication is increasing the demand for over-the-counter digestive products for the treatment of gastrointestinal disorders. Antacids are used to neutralize acidity and should, therefore, cause a dramatic increase in demand. According to a study conducted by the American Gastroenterological Association and published in the International Functional Foundation in February 2017, about one-third of the US population. Suffering from GERD. Market restraints include some side effects such as constipation, laxative effect and allergic reactions. In addition, people suffering from certain medical conditions are prone to adverse effects that worsen their state of health because people with heart disease may have problems due to the high amount of sodium present in antacids.

Asia-Pacific Antacid Market segmented and sub-segmented into the following categories and evaluated market size and forecast until 2024

By Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, And Pro-motility Agents

By Formulation Type: Tablet, Liquid And Powder

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Others.

By Country: India, China, Japan, Australia, South Korea and Rest of APAC

Some of the Prominent Companies leading the Asia-Pacific Antacid Market Profiled in the Report are:

  1. GlaxoSmithKline plc
  2. Abbott Laboratories
  3. Pfizer, Inc
  4. Sun Pharma
  5. Digene (Abbott India)
  6. Pudin Hara( Dabur)
  7. Gelusil (Pfizer)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Submarkets                

                                5.1.1 Introduction           

                                5.1.2 Chromatography  

                                5.1.3 E-Clinical Trial Solutions      

                                5.1.4 Wireless Health, Clinical Trial Management Systems(CTMS)              

                                5.1.5 Healthcare IT outsourcing 

                                5.1.6 Immunoassay        

                                5.1.7 Digital Pathology   

                                5.1.8 Next Generation sequencing(NGS)             

                                5.1.9 Proteomics             

                                5.1.10 Magnesium Compounds

                                5.1.11 , Aluminium Compounds

                                5.1.12 Calcium Compounds         

                                5.1.13 Antacids with Antiflatulents          

                                5.1.14  Y-o-Y Growth Analysis, By Submarkets    

                                5.1.15  Market Attractiveness Analysis, By Submarkets  

                                5.1.16  Market Share Analysis, By Submarkets   

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Novel Dietary Fibers           

                                5.2.3 Y-o-Y Growth Analysis, By Application         

                                5.2.4  Market Attractiveness Analysis, By Application      

                                5.2.5  Market Share Analysis, By Application       

                5.3 Ingredients                 

                                5.3.1 Introduction           

                                5.3.2 Protease  

                                5.3.3 Modified Starch    

                                5.3.4 Food & Beverage Starch    

                                5.3.5 Gellatin     

                                5.3.6 Collagen   

                                5.3.7 Carbohydrase        

                                5.3.8 Food & Beverage Sugars & its substitutes 

                                5.3.9 Y-o-Y Growth Analysis, By Ingredients        

                                5.3.10  Market Attractiveness Analysis, By Ingredients   

                                5.3.11  Market Share Analysis, By Ingredients    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Submarkets

                                                6.1.3.3 By Application

                                                6.1.3.5 By Ingredients

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Submarkets

                                                6.1.4.3 By Application

                                                6.1.4.4 By Ingredients

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Submarkets

                                                6.1.5.3 By Application

                                                6.1.5.4 By Ingredients

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 First Aid Only                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GSK                

                8.3 WellSpring Pharm                    

                8.4 Private Lable                              

                8.5 Pfizer                            

                8.6 Procter & Gamble                    

                8.7 Glaxosmithkline                       

                8.8 Boehringer Ingellheim Pharm                             

                8.9 Novaritis Consurmer Health                

                8.10 Johnson & Johnson                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Antacid Market By Submarkets, From 2019-2024( USD Billion )
  2. Asia-Pacific Chromatography Market By Region, From 2019-2024( USD Billion )
  3. Asia-Pacific E-Clinical Trial Solutions Market By Region, From 2019-2024( USD Billion )
  4. Asia-Pacific Wireless Health Market By Region, From 2019-2024( USD Billion )
  5. Asia-Pacific Clinical Trial Management System (CTMS) Market By Region, From 2019-2024( USD Billion )
  6. Asia-Pacific Healthcare IT Outsourcing Market By Region, From 2019-2024( USD Billion )
  7. Asia-Pacific Immunoassay Market By Region, From 2019-2024( USD Billion )
  8. Asia-Pacific Digital Pathology Market By Region, From 2019-2024( USD Billion )
  9. Asia-Pacific Next Generation Sequencing(NGS) Market By Region, From 2019-2024( USD Billion )
  10. Asia-Pacific Proteomics Market By Region, From 2019-2024( USD Billion )
  11. Asia-Pacific Antacids with Antiflatulents Market By Region, From 2019-2024( USD Billion )
  12. Asia-Pacific Antacid Market By Application, From 2019-2024( USD Billion )
  13. Asia-Pacific Novel Dietary Fibers Market By Region, From 2019-2024( USD Billion )
  14. Asia-Pacific Antacid Market By Ingredients, From 2019-2024( USD Billion )
  15. Asia-Pacific Protease Market By Region, From 2019-2024( USD Billion )
  16. Asia-Pacific Modified  Starch Market By Region, From 2019-2024( USD Billion )
  17. Asia-Pacific Food & Beverage Starch Market By Region, From 2019-2024( USD Billion )
  18. Asia-Pacific Gelatin Market By Region, From 2019-2024( USD Billion )
  19. Asia-Pacific Collagen Market By Region, From 2019-2024( USD Billion )
  20. Asia-Pacific Carbohydrase Market By Region, From 2019-2024( USD Billion )
  21. Asia-Pacific Food & Beverage Sugars & its subtitutes Market By Region, From 2019-2024( USD Billion )
  22. Japan Antacid Market By Submarkets, From 2019-2024( USD Billion )
  23. Japan Antacid Market By Application, From 2019-2024( USD Billion )
  24. Japan Antacid Market By Ingredients, From 2019-2024( USD Billion )
  25. China Antacid Market By Submarkets, From 2019-2024( USD Billion )
  26. China Antacid Market By Application, From 2019-2024( USD Billion )
  27. China Antacid Market By Ingredients, From 2019-2024( USD Billion )
  28. India Antacid Market By Submarkets, From 2019-2024( USD Billion )
  29. India Antacid Market By Application, From 2019-2024( USD Billion )
  30. India Antacid Market By Ingredients, From 2019-2024( USD Billion )
  31. Australia Antacid Market By Submarkets, From 2019-2024( USD Billion )
  32. Australia Antacid Market By Application, From 2019-2024( USD Billion )
  33. Australia Antacid Market By Ingredients, From 2019-2024( USD Billion )
  34. South Korea Antacid Market By Submarkets, From 2019-2024( USD Billion )
  35. South Korea Antacid Market By Application, From 2019-2024( USD Billion )
  36. South Korea Antacid Market By Ingredients, From 2019-2024( USD Billion )

 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample